Sam Lee - 16 Jul 2021 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Reporting relationship: President and Co-Interim CEO
Issuer ticker: COCP
Reported as of: 16 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jul 2021, 16:05:35 UTC
Next SEC filing: 03 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Sam Lee

Key filing fact

Sam Lee filed Form 4 for Cocrystal Pharma, Inc. (COCP) on 20 Jul 2021.

Key facts

This page summarizes Sam Lee's Form 4 filing for Cocrystal Pharma, Inc. (COCP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Jul 2021, 16:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

COCP transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 16 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $1.11
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code (the "Code").

Footnote F2

The stock options vest and become exercisable as follows, subject in each case to the limitations on exercisability of incentive stock options under Section 422 of the Code: one-half will vest on July 16, 2022 and the remaining half will vest in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to continued employment on each applicable vesting date.